UPDATED May 09, 2024
Companies with a Future performance score of at least 3, ordered by Future performance score.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
IRISDOREME | ₹78.35 | 0.3% | 6.8% | ₹6.4b | ₹101.00 | PE58.4x | E51.4% | n/a | Consumer Durables | ||
533286 | ₹400.35 | -9.3% | 150.9% | ₹81.5b | ₹345.00 | PE28.8x | E40.9% | 1.0% | Materials | ||
517146 | ₹334.05 | -10.2% | 43.7% | ₹101.8b | ₹471.00 | PE24x | E26.1% | 0.8% | Materials | ||
NEWBRY | kr3.06 | -5.6% | -43.3% | kr74.2m | kr8.00 | PS3.3x | E112.9% | n/a | Pharmaceuticals & Biotech | ||
KEBNI B | kr1.48 | -3.0% | 43.5% | kr402.4m | kr2.20 | PS4.4x | E90.4% | n/a | Tech | ||
CALTX | kr112.00 | 3.0% | -13.0% | kr6.0b | kr208.00 | PS5x | E49.9% | n/a | Pharmaceuticals & Biotech | ||
ACI | ₹619.90 | -3.1% | 14.4% | ₹76.5b | ₹743.00 | PE19.2x | E29.0% | 0.3% | Materials | ||
ELABS | kr15.52 | -0.4% | 37.1% | kr1.6b | kr25.00 | PS23.8x | E124.6% | n/a | Software | ||
GIG | kr31.25 | -8.4% | 12.2% | kr4.0b | kr45.25 | PE18.3x | E39.0% | n/a | Consumer Services | ||
MVW | kr8.05 | -3.6% | 15.0% | kr263.4m | kr13.00 | PS23.9x | E66.8% | n/a | Materials | ||
NOHAL | kr23.20 | -3.3% | -3.3% | kr907.3m | kr32.50 | PS8.9x | E56.0% | n/a | Food, Beverage & Tobacco | ||
GOKEX | ₹802.55 | -8.4% | 107.4% | ₹57.1b | ₹1,084.29 | PE42.6x | E38.7% | 0.1% | Consumer Durables | ||
TEJASNET | ₹1,079.70 | -2.9% | 60.9% | ₹184.4b | ₹1,100.00 | PE292.8x | E68.5% | 0% | Tech | ||
WAYS | kr21.95 | -2.2% | -52.2% | kr177.1m | kr39.75 | PS1.6x | E81.8% | 0% | Tech | ||
YGG | ฿6.95 | 1.5% | -6.1% | ฿4.2b | ฿10.75 | PE60.2x | E34.7% | 3.9% | Media | ||
517522 | ₹591.85 | -4.4% | -25.3% | ₹30.0b | ₹772.00 | PE41.8x | E33.5% | 0.3% | Materials | ||
AESI | US$22.99 | 4.8% | 34.1% | US$2.5b | US$26.00 | PE20.4x | E49.3% | 3.7% | Energy | ||
AXSM | US$73.68 | -0.7% | -5.5% | US$3.6b | US$123.56 | PS13.9x | E65.1% | n/a | Pharmaceuticals & Biotech | ||
ADOC | €8.61 | 2.4% | 149.9% | €123.0m | €9.70 | PS20.3x | E104.5% | n/a | Pharmaceuticals & Biotech | ||
ELF | US$170.43 | 6.2% | 90.3% | US$9.0b | US$205.92 | PE73.1x | E26.4% | n/a | Household | ||
TGTX | US$16.92 | 3.0% | -49.8% | US$2.5b | US$31.50 | PE58.8x | E48.0% | n/a | Pharmaceuticals & Biotech | ||
AGP | €8.32 | 0% | 155.2% | €144.0m | €12.75 | PE29.3x | E22.8% | n/a | Capital Goods | ||
ARES | US$142.44 | 5.8% | 74.8% | US$43.0b | US$147.64 | PE64.2x | E41.9% | 2.6% | Diversified Financials | ||
APLT | US$4.62 | 2.0% | 180.0% | US$538.1m | US$11.60 | PS52.8x | E81.9% | n/a | Pharmaceuticals & Biotech |